New Treatment For Patients With Paralysis

by Medindia Content Team on  May 28, 2004 at 5:03 PM General Health News
RSS Email Print This Page Comment
Font : A-A+

New Treatment For Patients With Paralysis
Investigators designed a combination therapy and tested it on rats with spinal cord contusions -- the most common cause of paralysis in humans. The combination therapy consisted of transplanted Schwann cells, which is a type of cell that insulates nerve cells, a cell messenger molecule called cyclic AMP, and the antidepressant Rolipram.

Following a spinal cord injury, the body typically does not provide a proper environment for nerve regeneration. However, with the new combination, nerve cells actually reconnected, so healing of the damaged nerve fibers was possible.

For the study researchers injected rats with Rolipram prior to transplanting Schwann cells to preserve cyclic AMP. Cyclic AMP helps enable the growth of nerve fibers that send signals up and down the spinal cord and central nervous system. The rats also received injections of cyclic AMP to promote the growth of nerve fibers past the injury site and into the spinal cord.

Specialists say this research will open up new possibilities for treating patients with spinal cord injuries and they say that more studies are needed to confirm their findings before the treatment is tested in humans.

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Bellīs Palsy 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive